FAFGX | URNQX | FAFGX / URNQX | |
Total Expense Ratio | 0.40 | 0.29 | 138% |
Annual Report Gross Expense Ratio | 0.40 | 0.29 | 138% |
Fund Existence | 5 years | 8 years | - |
Gain YTD | 13.444 | 11.023 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 328B | 7.71B | 4,253% |
Annual Yield % from dividends | 0.53 | 0.47 | 113% |
Returns for 1 year | 18.07 | 22.11 | 82% |
Returns for 3 years | 60.25 | 82.01 | 73% |
Returns for 5 years | N/A | 100.55 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 65.54 | 0.24 | +0.37% |
Janus Henderson Global Life Sciences A | |||
CICAX | 64.79 | 0.23 | +0.36% |
American Funds Invmt Co of Amer 529A | |||
NSIDX | 14.22 | 0.05 | +0.35% |
Northern Small Cap Index | |||
BRWTX | 27.37 | 0.08 | +0.29% |
MFS Blended Research Growth Eq R3 | |||
RTITX | 12.07 | -0.02 | -0.17% |
Russell Inv Multifactor Intl Eq M |